Sponsor Pipeline

Celest Therapeutics (Shanghai) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07680257 An Early Clinical Study to Evaluate the Safety and Efficacy of CLDN18.2 CAR T Cell… CLDN18.2 Positive Solid Tumors Recruiting
Get alerts when Celest Therapeutics (Shanghai) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free